Latest Drug Approvals news
FDA Expands Use of Vonvendi for Von Willebrand Disease
posted September 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Subcutaneous Leqembi for Treatment of Early Alzheimer Disease
posted September 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Papzimeos for Adults With Recurrent Respiratory Papillomatosis
posted August 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions Related Articles
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Monthly Specialist Briefings
Stay Connected
